• November 24, 2014
    DURHAM, N.C. - November 24, 2014 – Zoetis Inc. today announced the reintroduction of Zoamix® (zoalene), a versatile synthetic anticoccidial for the prevention and control of coccidiosis in broilers and turkeys.“The U.S. poultry industry loses an estimated $600 million a year to coccidiosis[i], so the return of Zoamix could not be coming at a better time,” said Don Waldrip, DVM, DACPV, a senior technical services veterinarian with Zoetis.He noted that U.S. poultry producers have not seen a newmore...
  • September 3, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Department of Agriculture (USDA) has granted a conditional license for a vaccine to help fight porcine epidemic diarrhea virus (PEDv) in pigs. The two-dose inactivated vaccine, licensed for use in healthy pregnant female pigs (sows and gilts), is designed to help them develop antibodies which can be transmitted to their newborn piglets. Zoetis anticipates the vaccine will be available tomore...
  • August 27, 2014
    DURHAM, N.C., August 27, 2014 – Zoetis Inc. has obtained a full license from the U.S. Department of Agriculture (USDA) to sell Poulvac® Bron GA 08, the first commercially available vaccine to reduce disease caused by Georgia 2008 (GA 08) Type infectious bronchitis virus (IBV) in poultry.Poulvac® Bron GA 08, a live vaccine, is licensed for vaccination of healthy chickens at one day of age or older as an aid in the reduction of disease caused by GA 08. The vaccine was licensed based on clinicalmore...
  • August 20, 2014
    FLORHAM PARK, N.J., Aug. 20, 2014 — Fostera™ PCV MH — the porcine circovirus (PCV) and Mycoplasma hyopneumoniae (M. hyo) combination vaccine that was built from the ground up by Zoetis — now has the longest demonstrated duration of immunity (DOI) to help protect pigs from porcine circovirus-associated disease (PCVAD) caused by PCV Type 2 (PCV2). The U.S. Department of Agriculture has granted the combination vaccine the extended label claim of at least 23 weeks of protection against PCV2, whichmore...
  • February 10, 2014
    FLORHAM PARK, N.J., Feb. 10, 2014 — Zoetis Inc. today announced a research partnership with Iowa State University (ISU) to identify and test a vaccine candidate to help control porcine epidemic diarrhea virus (PEDv) in the United States.  “Establishing this partnership further affirms our commitment to fighting this devastating virus,” said Gloria Basse, vice president, U.S. Pork Business Unit, Zoetis. “We look forward to working with the top researchers at Iowa State University to sharemore...
  • February 7, 2014
    DURHAM, N.C. - February 7, 2014 – Zoetis Inc. has obtained a conditional license from the U.S. Department of Agriculture (USDA) to market  the first commercially available vaccine for helping reduce disease caused by the Georgia 08 variant of infectious bronchitis virus (IBV) in poultry*. The vaccine is now available in Alabama, Florida, Georgia, Kentucky and Tennessee. The USDA agreed to issue a conditional license because the modified-live vaccine fills a special need, has beenmore...
  • December 17, 2013
    Zoetis is part of a consortium of 22 academic, industry and private enterprise organizations from 11 countries who are exploring new ways to ensure the sustainability of modern animal production. The consortium was recently awarded the largest animal health grant in EU history. Read the full press release here.more...
  • December 11, 2013
    Today the U.S. Food and Drug Administration finalized Guidance #213 establishing the procedures for voluntarily phasing out growth promotion indications for medically important antibiotics in alignment with Guidance #209 and published proposed changes to the Veterinary Feed Directive (VFD) regulation.The VFD regulation mandates the rules and responsibilities of licensed veterinarians in prescribing and administering medically important antibiotics in feed.  more...
  • October 22, 2013
    From the cows that provide the milk for a bowl of cereal to the deer nibbling on a shrub in the park, from sea lions working with their trainers at the zoo to puppies chasing balls in the yard, the connections humans have with animals are vast. This special relationship is explored in a new mobile exhibit from the Smithsonian.“Animal Connections: Our Journey Together,” a custom-built exhibition housed on an 18-wheel truck that expands into 1,000 square feet of space, will be on view on themore...
  • October 1, 2013
    FLORHAM PARK, N.J., October 1, 2013 – Zoetis Inc., (NYSE: ZTS) formerly the animal health business unit of Pfizer Inc., has notified the U.S. Food and Drug Administration (FDA) that the company will voluntarily withdraw the marketing authorizations (New Animal Drug Applications) for 3-Nitro (roxarsone)  and Carb-O-Sep ® (carbarsone). The decision to withdraw the marketing authorization for 3-Nitro, a feed medicine containing the organic arsenical roxarsone, follows the suspension ofmore...